Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-beta (Aβ) plaques, tau hyperphosphorylation, and chronic neuroinflammation. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.